<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Pharmacokinetics / Dosage forms / Biopharmaceutics Classification System / Bioequivalence / Dissolution testing / Abbreviated New Drug Application / Tablet / Bioavailability / Pharmaceutical sciences / Pharmacology / Clinical research
Date: 2012-10-02 07:46:38
Pharmaceutical industry
Pharmacokinetics
Dosage forms
Biopharmaceutics Classification System
Bioequivalence
Dissolution testing
Abbreviated New Drug Application
Tablet
Bioavailability
Pharmaceutical sciences
Pharmacology
Clinical research

WHO Prequalification of Medicines Programme Guidance Document October 2012

Add to Reading List

Source URL: apps.who.int

Download Document from Source Website

File Size: 48,39 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document